Researchers engineered an obligate‑anaerobe (Clostridium sporogenes) to carry an oxygen‑tolerance gene that only turns on after quorum sensing detects a large bacterial population inside a tumor, letting the microbe survive long enough to consume tumor tissue while (in principle) avoiding oxygenated healthy tissue. The team validated the circuit with a fluorescent reporter in ACS Synthetic Biology and says clinical trials are the next goal.
— If scalable, this approach could reshape cancer therapy options and force public discussion about clinical trials, biosafety rules for releasing engineered microbes into patients, and oversight for medical synthetic biology.
Jake Currie
2026.03.05
100% relevant
Waterloo researchers engineered C. sporogenes by attaching an oxygen‑tolerance gene to a quorum‑sensing circuit and demonstrated function with a fluorescent reporter in an ACS Synthetic Biology study, with clinical trials planned.
← Back to All Ideas